Stock Events

Stock Events

Kraig Biocraft Laboratories 

$0.106350
10
-$0.00-1.86% 19:59 Today

Statistics

Day High
0.11
Day Low
0.1015
52W High
0.16
52W Low
0.07
Volume
500,737
Avg. Volume
1,171,231
Mkt Cap
117.05M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

14NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0
-0
-0
-0
Expected EPS
N/A
Actual EPS
-0.0008

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-3.62MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow KBLB. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bolt Biotherapeutics
BOLT
Mkt Cap7.78M
Bolt Biotherapeutics, Inc. is involved in biotechnology and drug development, competing in the broader biotech market.
CRISPR Therapeutics
CRSP
Mkt Cap5.92B
CRISPR Therapeutics AG specializes in gene editing, a technology that could be applied similarly to KBLB's genetic modification techniques.
Editas Medicine
EDIT
Mkt Cap560.14M
Editas Medicine, Inc. works on genome editing, directly competing with KBLB's genetic engineering approach.
Intellia Therapeutics
NTLA
Mkt Cap2.45B
Intellia Therapeutics, Inc. is a leader in CRISPR/Cas9 technology, offering competitive gene editing capabilities.
Pacific Biosciences of California
PACB
Mkt Cap521.81M
Pacific Biosciences of California, Inc. provides sequencing technologies, essential for genetic research like KBLB's.
Sangamo Therapeutics
SGMO
Mkt Cap30.66M
Sangamo Therapeutics, Inc. focuses on genomic medicine, competing in the genetic engineering space.
Syros Pharmaceuticals
SYRS
Mkt Cap2,683
Syros Pharmaceuticals, Inc. is involved in gene control, which is foundational to genetic engineering and biotech innovations.
Twist Bioscience
TWST
Mkt Cap6.18B
Twist Bioscience Corporation specializes in synthetic DNA, directly competing with KBLB's synthetic biology efforts.

About

Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. The company’s products are used in performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics, and other applications; military and police for its ballistic protection; and geotextiles, safe and protective clothing, textiles used in transportation and buildings, and functional and sportive textiles. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.
Show more...
CEO
Mr. Kim Kraig Thompson
Employees
14
Country
United States
ISIN
US50075W1045

Listings

OTC Link
US
KBLB

0 Comments

Share your thoughts

FAQ

What is Kraig Biocraft Laboratories stock price today?▼
The current price of KBLB is $0.11 USD — it has decreased by -1.86% in the past 24 hours. Watch Kraig Biocraft Laboratories stock price performance more closely on the chart.
What is Kraig Biocraft Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Kraig Biocraft Laboratories stocks are traded under the ticker KBLB.
Is Kraig Biocraft Laboratories stock price growing?▼
KBLB stock has risen by +5.3% compared to the previous week, the month change is a -11.67% fall, over the last year Kraig Biocraft Laboratories has showed a +26.08% increase.
What is Kraig Biocraft Laboratories market cap?▼
Today Kraig Biocraft Laboratories has the market capitalization of 117.05M
What were Kraig Biocraft Laboratories earnings last quarter?▼
KBLB earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kraig Biocraft Laboratories revenue for the last year?▼
Kraig Biocraft Laboratories revenue for the last year amounts to 0 USD.
What is Kraig Biocraft Laboratories net income for the last year?▼
KBLB net income for the last year is -3.62M USD.
How many employees does Kraig Biocraft Laboratories have?▼
As of July 08, 2026, the company has 14 employees.
In which sector is Kraig Biocraft Laboratories located?▼
Kraig Biocraft Laboratories operates in the Materials sector.
When did Kraig Biocraft Laboratories complete a stock split?▼
The last stock split for Kraig Biocraft Laboratories was on May 28, 2009 with a ratio of 10:1.
Where is Kraig Biocraft Laboratories headquartered?▼
Kraig Biocraft Laboratories is headquartered in Ann Arbor, United States.